Medications That Decrease Afterload
Several medication classes decrease afterload through vasodilation, including ACE inhibitors, ARBs, ARNIs, hydralazine, nitrates, and calcium channel blockers, with specific dosing strategies varying by clinical indication.
Cardiovascular Medications That Reduce Afterload
Heart Failure Management
ACE Inhibitors, ARBs, and ARNIs are cornerstone therapies that reduce afterload in heart failure with reduced ejection fraction (HFrEF) 1. These medications are initiated at low doses and titrated upward to target doses proven in clinical trials 1:
- ACE inhibitors/ARBs: Start low and uptitrate to target doses over weeks to months 1
- ARNi (sacubitril/valsartan): Initial dose 49 mg sacubitril/51 mg valsartan twice daily, target 97 mg/103 mg twice daily 1
- Hydralazine-isosorbide dinitrate combination: Particularly effective in African American patients, starting at 20-30 mg isosorbide dinitrate with 25-50 mg hydralazine 3-4 times daily, targeting 120 mg isosorbide dinitrate and 300 mg hydralazine total daily 1
Acute Rate Control in Atrial Fibrillation
Calcium channel blockers (diltiazem and verapamil) reduce afterload while controlling heart rate 1:
- Diltiazem: Loading dose 0.25 mg/kg IV over 2 minutes, followed by maintenance infusion 5-15 mg/h 1
- Verapamil: Loading dose 5-10 mg (0.075-0.15 mg/kg) IV over 2 minutes, may repeat 10 mg after 30 minutes 1
- Both agents should be avoided in patients with decompensated systolic heart failure or pre-existing ventricular dysfunction 1
Important Considerations
Beta-blockers also reduce afterload indirectly through negative chronotropic and inotropic effects 1:
- Esmolol: 500 mcg/kg IV bolus over 1 minute, then 50-300 mcg/kg/min infusion 1
- Metoprolol: Initial 2.5-5 mg IV bolus, can repeat up to 3 doses 1
Common Pitfalls and Caveats
Avoid calcium channel blockers in patients with HFrEF as they can worsen heart failure despite reducing afterload 1. Monitor blood pressure closely when initiating or uptitrating afterload-reducing agents, as hypotension is a common adverse effect 1. Renal function monitoring is essential with ACE inhibitors, ARBs, and ARNIs, particularly checking creatinine and potassium within 1 week of initiation or dose escalation 1. Do not discontinue these medications routinely even when GFR falls below 30 mL/min/1.73 m², as they remain nephroprotective 1.